On 12 September 2018 Barcelona Commercial Court Number 5 dismissed a preliminary injunction request filed by Merck Sharp & Dohme (MSD) regarding the commercialisation of generic medicinal products comprising ezetimibe and simvastatin.
On 12 September 2018 Barcelona Commercial Court Number 5 dismissed a preliminary injunction request filed by Merck Sharp & Dohme (MSD) regarding the commercialisation of generic medicinal products comprising ezetimibe and simvastatin.